SS Innovations International Files 8-K

Ticker: SSII · Form: 8-K · Filed: 2025-03-07T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, corporate-filing, financial-statements

TL;DR

SS Innovations International filed an 8-K on March 7, 2025, reporting other events and financial statements.

AI Summary

SS Innovations International, Inc. filed an 8-K on March 7, 2025, reporting other events and financial statements. The company, formerly known as AVRA Medical Robotics, Inc. until June 1, 2016, is incorporated in Florida and headquartered in Fort Lauderdale.

Why It Matters

This filing indicates routine corporate reporting, including financial statements and other events, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This is a standard 8-K filing for reporting corporate events and financial statements, with no immediate indication of significant risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 7, 2025.

When was SS Innovations International, Inc. previously known by another name?

SS Innovations International, Inc. was formerly known as AVRA Medical Robotics, Inc. until June 1, 2016.

In which state is SS Innovations International, Inc. incorporated?

SS Innovations International, Inc. is incorporated in Florida.

What is the principal executive office address of the company?

The principal executive office address is 1600 SE 15th Street, #512, Fort Lauderdale, Florida 33316.

What is the SEC file number for SS Innovations International, Inc.?

The SEC file number for SS Innovations International, Inc. is 000-56608.

From the Filing

0001213900-25-021748.txt : 20250307 0001213900-25-021748.hdr.sgml : 20250307 20250307162130 ACCESSION NUMBER: 0001213900-25-021748 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250307 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250307 DATE AS OF CHANGE: 20250307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SS Innovations International, Inc. CENTRAL INDEX KEY: 0001676163 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 473478854 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56608 FILM NUMBER: 25720399 BUSINESS ADDRESS: STREET 1: 1600 SE 15TH STREET STREET 2: #512 CITY: FORT LAUDERDALE STATE: FL ZIP: 33316 BUSINESS PHONE: (954) 478-1410 MAIL ADDRESS: STREET 1: 1600 SE 15TH STREET STREET 2: #512 CITY: FORT LAUDERDALE STATE: FL ZIP: 33316 FORMER COMPANY: FORMER CONFORMED NAME: AVRA Medical Robotics, Inc. DATE OF NAME CHANGE: 20160601 8-K 1 ea0233663-8k_ssinno.htm CURRENT REPORT false 0001676163 0001676163 2025-03-07 2025-03-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of report (Date of earliest event reported): March 7, 2025   SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter)   Florida   000-56608   47-3478854 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   1600 SE 15th Street , #512 Fort Lauderdale , Florida   33316 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s telephone number, including area code: (954) 478-1410     (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each Class   Trading Symbol   Name of each exchange on which registered None   N/A   N/A   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             As used in this Current Report on Form 8-K (this “ Report ”), the terms “ SSi ,” “ the Company ,” “ we ,” “ us ” and “ our ” refer to SS Innovations International, Inc. and its subsidiaries.   Item 8.01 Other Events.   On March 7, 2025, SSi issued a press release announcing announced the launch of its 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025) ), being held in Gur

View on Read The Filing